Australian researchers have received funding to undertake an in-vitro study of live brain cells in Parkinson’s disease patients.
This work is critical in laying the foundations for screening new therapeutics that are needed to stop the debilitating progression of Parkinson’s. If successful for this Parkinson’s project, our approach may be extended to all kinds of brain disorders.
Cedric Bardy, leader of the study from the South Australian Health and Medical Research Institute (SAHMRI), said the team was granted funding from Perpetual IMPACT Philanthropy to discover new molecular targets to treat Parkinson’s.
One of the major issues in developing cures for the disease is a lack of access to live neurons to study the disease and test new drugs.
Bardy’s team has developed a platform on which live human neurons can be developed and will use the platform to compare biological differences between neurons from Parkinson’s patients and healthy subjects.
If you are looking for more articles and resources for Impact Philanthropy, take a look at these Giving Compass selections related to impact giving and Impact Philanthropy.
Looking for a way to get involved?
If you are looking for opportunities to learn and connect with others interested in the topic of Diseases and Cures, take a look at these events, galas, conferences and volunteering opportunities aggregated by Giving Compass.
Are you ready to give?
If you are ready to take action and invest in causes for Diseases and Cures, check out these Giving Funds, Charitable Organizations and Projects related to Diseases and Cures.